Atria Investments, Inc - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 333 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 1.69 and the average weighting 0.2%.

Quarter-by-quarter ownership
Atria Investments, Inc ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$437,000
+97.7%
7,233
+96.1%
0.01%
+50.0%
Q3 2019$221,000
-30.9%
3,688
-22.8%
0.01%
-33.3%
Q2 2019$320,000
-40.5%
4,780
-27.9%
0.01%
-47.8%
Q1 2019$538,000
+31.2%
6,632
-12.7%
0.02%
+27.8%
Q4 2018$410,000
+12.3%
7,593
+7.4%
0.02%
+28.6%
Q3 2018$365,0007,0710.01%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Bellevue Group AG 9,463,400$418,566,0006.01%
Tweedy, Browne Co LLC 2,722,988$120,438,0005.30%
BVF INC/IL 2,872,953$127,071,0005.25%
Sicart Associates LLC 253,976$11,233,0003.98%
Parkman Healthcare Partners LLC 241,945$10,701,0003.04%
Camber Capital Management LP 1,925,000$85,143,0002.61%
Privium Fund Management B.V. 148,807$6,589,0002.39%
SECTOR GAMMA AS 164,223$7,264,0001.87%
HANSEATIC MANAGEMENT SERVICES INC 10,993$486,0001.31%
BRANDYWINE MANAGERS, LLC 8,460$374,0001.23%
View complete list of IONIS PHARMACEUTICALS INC shareholders